The hemodynamic effects of intravenous paracetamol (acetaminophen) in patients with chronic liver disease undergoing liver transplantation: a pilot study.
Laurence WeinbergElizabeth ChiamJadon KarpLeonid ChurilovRinaldo BellomoPublished in: BMC research notes (2021)
Twenty-four participants undergoing liver transplantation surgery were randomly assigned to receive a single bolus of IV paracetamol (1 g paracetamol + 3.91 g mannitol per 100 mL) (n = 12) or placebo (0.9% Saline 100 mL) (n = 12). All participants completed their study intervention, and there were no breaches or violations of the trial protocol. Baseline characteristics were similar in both groups. There were no significant differences regarding surgical duration, intraoperative use of fluids, and intraoperative noradrenaline use. After the administration of paracetamol there were no significant differences observed in blood pressure or other hemodynamic parameters when compared to placebo.
Keyphrases
- phase iii
- blood pressure
- anti inflammatory drugs
- randomized controlled trial
- minimally invasive
- double blind
- clinical trial
- patients undergoing
- study protocol
- coronary artery bypass
- high dose
- hypertensive patients
- open label
- coronary artery disease
- heart rate
- skeletal muscle
- liver injury
- acute coronary syndrome
- weight loss
- surgical site infection